Part I of this Report is the subject of a Form 12b-25
which has been contemporaneously filed herewith
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the Quarter Ended Commission File Number
March 31, 1996 33-16757-D
MEDIZONE CANADA LIMITED
(Exact name of registrant as specified in its charter)
Utah 87-0431771
(State or other jurisdiction (I.R.S. Employer
of incorporation Identification No.)
or organization)
123 East 54th Street
Suite 7B
New York, New York 10022
(212) 421-0303
(Address, including zip code and telephone number, including
area code of registrant's principal executive offices)
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes |X| No
At August 9, 1996, there were outstanding 36,493,333 shares of the
registrant's common stock.
Page 1 of 4 pages
<PAGE>
MEDIZONE CANADA LIMITED AND SUBSIDIARY
Index
June 30, 1996
Page
PART I - FINANCIAL INFORMATION Number
- ------------------------------ ------
Part I of this report is the subject of a Form 12b-25.
PART II - OTHER INFORMATION
- ---------------------------
Item 4. - Submission of Matters to a vote of Securities Holders 3
Item 6. - Exhibits and Reports on Form 8-K 3
Signatures 4
Page 2 of 4 pages
<PAGE>
PART II - OTHER INFORMATION
---------------------------
Item 4. Submission of Matters to a
Vote of Securities Holders
--------------------------
On July 10, 1996, Medizone Canada Limited (the "Registrant") held its
annual meeting of shareholders at which the matters described below were voted
upon by the Registrant's shareholders.
A. Election of Directors
---------------------
Three directors, comprising the entire board, were elected to the
Registrant's Board of Directors. These individuals will serve as directors until
the Registrant's next annual meeting of shareholders and until their successors
have been elected and shall have been qualified.
These individuals, and their tabulated votes, are as follows:
Votes
Votes for Against Abstentions
-------- ------- -----------
Joseph S. Latino 24,747,100 0 0
George Handel 24,747,100 0 0
John D. Pealer 24,747,100 0 0
B. Ratification of Appointment of
Independent Public Accountant
------------------------------
The Registrant's stockholders ratified the selection of Andersen
Andersen & Strong, L.C. as the Registrant's independent public accountant for
the 1996 calendar year by the following vote:
Votes for Vote Against Abstention
- --------- ------------ ----------
24,747,100 0 0
Item 6. Exhibits and Reports on Form 8-K
--------------------------------
(b) No reports on Form 8-K were filed by the Registrant this quarter.
Page 3 of 4 pages
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
MEDIZONE CANADA LIMITED
(Registrant)
/s/Arthur P. Bergeron
---------------------------
Arthur P. Bergeron
Vice President
and Chief Financial Officer
August 14, 1996
Page 4 of 4 pages
